Skip to main content
GeneralHomeInvestorsNewsUzedy

Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia

By August 31, 2021March 15th, 2024No Comments1 min read